Back to Resources

Venture Debt in 2026: When to Use It and What It Really Costs

Fundraising

Share
Executive Summary: Venture debt has matured into a mainstream financing tool for UK growth companies, but its true cost is consistently underestimated. When interest rate spread, warrant coverage, arrangement fees and original issue discount are properly modelled, a £5m facility often carries an effective APR of 14 to 18 per cent. This article sets out precisely when venture debt adds value, when it destroys it, and how to build the cost comparison correctly.

What Venture Debt Is and How It Differs from Traditional Bank Debt

Venture debt is a form of debt financing extended to venture-backed companies that typically lack the tangible assets or cash flow history required for conventional bank lending. It emerged in the United States in the 1970s and has grown substantially in the UK over the past decade, with the British Business Bank reporting that the market for venture and growth lending to UK businesses reached approximately £4.5 billion in 2024, a significant increase from the £2.8 billion recorded in 2020.

Unlike a commercial term loan from a high street bank, venture debt does not require the borrower to demonstrate a history of profitable trading or to provide hard asset collateral. Instead, the lender underwrites the quality of the equity investors behind the company, the credibility of the business plan, and the probability of a future equity raise that will provide the repayment source. This means venture debt is almost exclusively available to companies that have already raised institutional venture capital from recognised investors.

The structural differences from traditional bank debt are important to understand before modelling the cost:

  • No amortisation until maturity (or a short interest-only period followed by amortisation): Most venture debt facilities have an initial period of 12 to 24 months during which only interest is paid, followed by a principal repayment period. This preserves cash during the growth phase.
  • Warrant coverage: Lenders typically receive warrants to purchase equity in the borrower, exercisable at the most recent round price. This is the mechanism by which the lender participates in the upside of a successful business, compensating for the higher credit risk relative to a traditional bank loan.
  • Revenue or MRR-based covenants rather than EBITDA covenants: Pre-revenue or early-revenue companies cannot meet traditional financial covenants. Venture debt covenants are typically structured around minimum cash balances, minimum monthly recurring revenue growth, and occasionally minimum gross margin thresholds.
  • MAC clause: A material adverse change clause allows the lender to call an event of default if there has been a material adverse change in the business. This is often the most feared covenant in a venture debt agreement and the one most likely to be triggered unexpectedly.

When Venture Debt Makes Sense: The Right Use Cases

Venture debt is not universally beneficial. It introduces fixed obligations into a balance sheet that may already carry substantial operational risk. The correct question is not whether to raise venture debt, but whether the specific use case justifies the all-in cost.

The three scenarios where venture debt is genuinely additive are the following:

Bridge to next round: If your Series A close is 6 to 9 months away and you have 4 months of runway at current burn, venture debt can bridge the gap without requiring you to raise at a depressed valuation. The debt cost (say, 16 per cent effective APR on a £3m facility) is substantially less dilutive than a bridging equity round at a 20 per cent discount to the anticipated Series A price. This is the most compelling use case and the one where the cost comparison works most clearly in debt's favour.

Runway extension without dilution: If you have just closed a round and have good capital efficiency, raising venture debt alongside the equity allows you to extend your runway to 24 to 30 months rather than 18 months, reducing the risk that market conditions force a down round at your next raise. The key condition is that you have high confidence in achieving the milestones that will support the next round before the debt matures.

Specific asset or contract financing: If you have a specific large customer contract, a product development sprint, or a capital equipment purchase where the return on investment is clearly quantifiable, debt can fund it at a lower cost than equity would imply. The asset being financed should have a payback period shorter than the debt maturity.

Venture debt is not the right instrument for covering operating losses with no clear path to improvement, for financing exploratory R&D with uncertain returns, or for companies with less than 6 months of runway who may trigger a covenant breach before the next raise.

The Real All-In Cost: A Worked Example

The headline interest rate on a venture debt facility is almost never the all-in cost. A full cost calculation must include the interest margin, the warrant cost, the arrangement fee, and in some cases an original issue discount. Here is a worked example for a £5 million facility:

Interest Rate
SONIA + 7%At 5.2% SONIA (Feb 2026): approximately 12.2% per annum cash interest
Warrant Coverage
1% of facility£50,000 in warrants at last round price. Dilutive but non-cash at draw-down
Arrangement Fee
1.5%£75,000 paid at draw-down, reducing net proceeds to £4.925m
Effective APR
~15.8%Including all cash costs over a 30-month facility (12-month interest-only, 18-month amortisation)

The effective APR calculation works as follows for the £5m facility with these parameters: arrangement fee of £75,000 paid upfront, interest of 12.2 per cent per annum on the drawn balance, 12 months interest-only (cash interest: £610,000), then 18 months of equal principal repayments with declining interest. Total cash cost over the facility life: approximately £1,008,000. Net proceeds after arrangement fee: £4,925,000. Solving for the internal rate of return of that cash flow stream gives an effective APR of approximately 15.8 per cent. The warrant cost is additional and dilutive but non-cash.

At SONIA + 9 per cent (the top of the typical range), the same calculation produces an effective APR of approximately 18.3 per cent. This is the number that should be entered into your cost of capital model, not the headline margin.

"The warrant coverage on a venture debt deal is frequently dismissed as a rounding error. At a 1.5 per cent coverage rate and a £5m facility on a company valued at £30m, the lender receives warrants over 0.25 per cent of the company. At a £150m exit, that is £375,000 of value transferred. Model it properly."

Key Covenants and Events of Default

Understanding covenants before signing is critical. Venture debt covenants that are reasonable at draw-down can become binding constraints if trading deteriorates, and an event of default on a venture debt facility is one of the most damaging events a growth company can experience: it triggers cross-default clauses, can block equity fundraising, and may require immediate repayment of the full facility.

The most common covenants in UK venture debt agreements in 2026 are as follows:

  • Minimum cash covenant: Requires the borrower to maintain a minimum cash balance at all times, typically set at 2 to 4 months of current monthly burn rate. This is the covenant most likely to bite in a deteriorating scenario. Model it carefully against your downside runway projection.
  • Minimum MRR covenant: For SaaS or subscription businesses, a floor on monthly recurring revenue, typically set at 70 to 80 per cent of MRR at the time of draw-down with a testing frequency of quarterly. A sudden loss of a large customer can trigger this covenant.
  • Material Adverse Change clause: Deliberately broad. The lender has discretion to determine what constitutes a MAC. Regulatory action, loss of key personnel, or a failed fundraising could all theoretically qualify. Negotiate the MAC definition as specifically as possible before signing.
  • Change of control provision: The facility becomes immediately repayable upon a change of control. This is generally acceptable in an M&A context (the acquirer pays it off at closing) but must be flagged to any potential acquirer early in due diligence.

The UK Market in 2026: Active Lenders

The venture debt market in the UK has consolidated somewhat since the Silicon Valley Bank failure in March 2023, but the lender universe remains active. The principal providers operating in the UK market as of February 2026 are:

Lender
Typical Facility Size
Notable Characteristics
HSBC Innovation Banking
£2m to £25m+
Successor to SVB UK; strong Series A to C focus; combined banking and debt relationships
Kreos Capital
£3m to £20m
Pan-European specialist; revenue and milestone-linked structures; acquired by BlackRock in 2023
TriplePoint Capital
£2m to £15m
US-headquartered with active UK book; life sciences and deep tech focus
Lighter Capital
£200k to £4m
Revenue-based financing; no warrants; repayment as percentage of monthly revenue; suitable for lower ARR businesses
British Business Bank programmes
Via accredited lenders
ENABLE Guarantee programme supports regional and specialist lenders; useful for companies outside London with fewer lender options

Venture Debt vs Equity: A Cost Comparison

The correct comparison is not debt cost versus equity cost in isolation. It is the dilution avoided by using debt versus the cash cost of the debt, calibrated by exit valuation. Here is a worked comparison for a company raising £5m:

Scenario A assumes the company raises £5m of equity at a £25m pre-money valuation, giving away 16.7 per cent of the company. At a £100m exit, that 16.7 per cent is worth £16.7m in proceeds transferred to new investors. At a £200m exit, it is £33.4m.

Scenario B assumes the company raises £5m of venture debt at the terms above (effective APR approximately 15.8 per cent, warrant coverage of 1 per cent of facility). Total cash cost over 30 months: approximately £1,008,000. Warrant dilution: approximately 0.25 per cent of the cap table at the £20m post-money valuation implied by the same scenario. At a £100m exit, the warrant holder receives approximately £250,000. Total economic cost of the venture debt: approximately £1.26m regardless of exit valuation (the warrant is the variable element, but on a small coverage amount it is modest).

The conclusion is clear: for a company that has a credible path to a material exit, venture debt is substantially less expensive than equity in economic terms, even at a 16 per cent effective APR. The calculus only inverts if the company fails to raise the next round and defaults on the facility, at which point the debt becomes expensive in a manner that equity is not. Venture debt rewards companies that execute; it penalises those that miss their plan.

Decision framework: Venture debt is additive if: (1) you have at least 6 months of runway before draw-down, (2) your next equity raise has a probability of success above 70 per cent in your base case, (3) the specific use of proceeds has a clearly defined return, and (4) you can model compliance with every covenant under your downside scenario without a breach. If any of these conditions is absent, think carefully before signing.

Key Takeaways

  • Venture debt is a legitimate and cost-efficient financing tool for UK growth companies, but only in the right circumstances: bridge to next round, runway extension, or specific asset financing.
  • The all-in cost of a typical UK venture debt facility in February 2026 is approximately 14 to 18 per cent effective APR when interest spread, arrangement fee and warrant coverage are properly modelled.
  • SONIA + 6 to 9 per cent is the typical interest margin range; warrant coverage of 0.5 to 2 per cent of facility is standard; arrangement fees of 1 to 2 per cent are typical.
  • Covenant modelling is as important as cost modelling. The minimum cash covenant and MAC clause are the two most dangerous provisions; negotiate them carefully and stress-test them against your downside scenario.
  • In a straight cost comparison against equity, venture debt almost always wins for companies with credible exit trajectories. The value of dilution avoided typically exceeds the cash cost of the debt by a factor of 5 to 20 times at a meaningful exit valuation.
  • HSBC Innovation Banking, Kreos, TriplePoint and Lighter Capital are the most active lenders in the UK market in 2026. Run a competitive process across at least two lenders before accepting terms.
  • Revenue-based financing from providers such as Lighter Capital is an alternative for companies with established MRR but insufficient equity backing for traditional venture debt.

Work Together

Need this applied to
your business?

Modelling the true cost of venture debt, comparing it to equity dilution, and stress-testing covenants against your downside scenario requires CFO-level financial modelling. That is what we do.

Book a Free Discovery Call →